5th Jan 2022 17:34
(Alliance News) - Goldman Sachs International said Wednesday that IngreLux Sarl intends to sell around 65 million shares in Wollaston, Northamptonshire-based footwear and clothing firm Dr Martens PLC.
IngreLux currently owns 429.1 million shares in Dr Martens, which reflects around 43% of the company's issued share capital, while the shares to be sold through a placing represent a 6.5% stake.
The price per share will be determined through the accelerated bookbuilding process to institutional investors. Barclays Bank PLC and Goldman Sachs International will act as joint bookrunners for the placing.
Dr Martens will not gain any proceeds from the placing.
Shares in Dr Martens closed 2.0% lower at 421.40 pence on Wednesday in London.
By Dayo Laniyan; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Dr. Martens